Company Filing History:
2 out of 371 
1 out of 13 
1 out of 322 
Years Active: 2001-2006
Title: The Innovative Path of Alan Duncan Robertson: A Pioneering Inventor
Introduction:
Alan Duncan Robertson, a prolific inventor based in South Melbourne, AU, has made significant contributions to the field of pharmaceuticals with a total of four patents to his name. His groundbreaking work has revolutionized the way we view estradiol conjugates and cannabinoid receptor modulation, showcasing his prowess in the realm of innovation.
Latest Patents:
Robertson's latest patents include cutting-edge inventions such as "Estradiol Conjugates and Uses Thereof," which introduces a conjugated prodrug of an estradiol compound linked to a biological activity modifying agent, and "3-Oxadiazol-5-yl-1-Aminoalkyl-1H-Indole Derivatives," which focuses on aminoalkylindole compounds for modulating the activity of cannabinoid receptors in analgesic therapy.
Career Highlights:
Having honed his skills at esteemed institutions like Monash University and Amrad Operations Pty Ltd, Robertson has displayed an unwavering commitment to advancing pharmaceutical research. His innovative approach to drug development has garnered recognition within the scientific community and beyond.
Collaborations:
Throughout his illustrious career, Robertson has had the privilege of collaborating with esteemed professionals such as Maree Patricia Collis and Bevyn Jarrott. These partnerships have been instrumental in bringing his inventive ideas to fruition and expanding the frontiers of pharmaceutical innovation.
Conclusion:
In conclusion, Alan Duncan Robertson stands as a beacon of ingenuity in the realm of pharmaceutical inventions. His dedication to pushing boundaries and creating novel solutions underscores his status as a pioneering inventor, poised to make lasting contributions to the field for years to come.